ProfileGDS4718 / 1563907_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 15% 18% 12% 14% 13% 16% 20% 19% 10% 15% 17% 16% 18% 17% 17% 14% 14% 18% 11% 17% 17% 17% 12% 12% 16% 18% 14% 12% 13% 17% 17% 22% 20% 15% 11% 10% 13% 19% 16% 17% 16% 15% 19% 15% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9574515
GSM549102patient 115, normal, homogenized [OPG study]4.0749918
GSM549104patient 119, normal, homogenized [OPG study]3.8194112
GSM549108patient 138, normal, homogenized [OPG study]3.9635214
GSM549119patient 077, normal, homogenized [OPG study]3.8971613
GSM549133patient 032, cancer, homogenized [OPG study]3.9405716
GSM549139patient 042, cancer, homogenized [OPG study]4.1085220
GSM549099patient 107, normal, homogenized [OPG study]4.1140419
GSM549109patient 139, normal, homogenized [OPG study]3.824710
GSM549110patient 046, normal, homogenized [OPG study]3.9765615
GSM549114patient 063, normal, homogenized [OPG study]4.0122217
GSM549122patient 082, normal, homogenized [OPG study]4.002316
GSM549134patient 033, cancer, homogenized [OPG study]4.0823318
GSM549136patient 036, cancer, homogenized [OPG study]4.0005717
GSM549140patient 044, cancer, homogenized [OPG study]4.0102517
GSM549111patient 047, normal, homogenized [OPG study]3.9230314
GSM549113patient 057, normal, homogenized [OPG study]3.8752914
GSM549132patient 031, cancer, homogenized [OPG study]4.0452218
GSM549137patient 038, cancer, homogenized [OPG study]3.8104411
GSM549142patient 047, cancer, homogenized [OPG study]4.096917
GSM549100patient 110, normal, homogenized [OPG study]4.0270617
GSM549107patient 135, normal, homogenized [OPG study]4.0203417
GSM549115patient 068, normal, homogenized [OPG study]3.8127912
GSM549116patient 072, normal, homogenized [OPG study]3.8535412
GSM549120patient 078, normal, homogenized [OPG study]4.0018916
GSM549131patient 030, cancer, homogenized [OPG study]4.0357918
GSM549118patient 074, normal, homogenized [OPG study]3.9191114
GSM549129patient 027, cancer, homogenized [OPG study]3.8829212
GSM549123patient 088, normal, homogenized [OPG study]3.8960813
GSM549124patient 006, cancer, homogenized [OPG study]4.0893517
GSM549126patient 015, cancer, homogenized [OPG study]4.0156217
GSM549128patient 025, cancer, homogenized [OPG study]4.2067622
GSM549103patient 117, normal, homogenized [OPG study]4.193420
GSM549117patient 073, normal, homogenized [OPG study]3.9450315
GSM549138patient 041, cancer, homogenized [OPG study]3.8153811
GSM549141patient 045, cancer, homogenized [OPG study]3.748910
GSM549130patient 028, cancer, homogenized [OPG study]3.8893413
GSM549101patient 111, normal, homogenized [OPG study]4.1099619
GSM549105patient 128, normal, homogenized [OPG study]4.0070616
GSM549106patient 134, normal, homogenized [OPG study]3.9782317
GSM549112patient 048, normal, homogenized [OPG study]4.0019216
GSM549125patient 011, cancer, homogenized [OPG study]3.9880115
GSM549127patient 024, cancer, homogenized [OPG study]4.0711519
GSM549135patient 035, cancer, homogenized [OPG study]3.9031315